According to this study, the global CXO Services market size will reach US$ 161583 million by 2031.
CXO Services refer to a broad category of outsourced services provided to pharmaceutical, biotechnology, and life sciences companies to support the development, manufacturing, and commercialization of drugs and therapeutics. The term "CXO" collectively represents contract-based services, in this report, CXO include CRO and CDMO.
United States market for CXO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for CXO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for CXO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key CXO Services players cover Lonza, Catalent, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Boehringer Ingelheim, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淐XO Services Industry Forecast鈥� looks at past sales and reviews total world CXO Services sales in 2024, providing a comprehensive analysis by region and market sector of projected CXO Services sales for 2025 through 2031. With CXO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CXO Services industry.
This Insight Report provides a comprehensive analysis of the global CXO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CXO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global CXO Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CXO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CXO Services.
This report presents a comprehensive overview, market shares, and growth opportunities of CXO Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
CRO
CDMO
Segmentation by Application:
Pharmaceutical Companies
Medical Device Companies
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Lonza
Catalent
Samsung Biologics
FUJIFILM Diosynth Biotechnologies
Boehringer Ingelheim
Wuxi AppTec
Charles River
Labcorp
Eurofins Scientific
PPD, Inc.
ICON Plc.
Pharmaron
Recipharm
Thermo Fisher Scientific
AGC Biologics
Rentschler Biopharma
KBI Biopharma
Siegfried
Aenova Group
GenScript
ProBioGen
Northway Biotech
3P Biopharmaceuticals
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Crown Bioscience
Champion Oncology
IQVIA
Parexel
Syneos Health
PRA Health Sciences
Medpace Holdings
Tigermed
Boji Medical Technology
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global CXO Services Market Size (2020-2031)
2.1.2 CXO Services Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for CXO Services by Country/Region (2020, 2024 & 2031)
2.2 CXO Services Segment by Type
2.2.1 CRO
2.2.2 CDMO
2.3 CXO Services Market Size by Type
2.3.1 CXO Services Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global CXO Services Market Size Market Share by Type (2020-2025)
2.4 CXO Services Segment by Application
2.4.1 Pharmaceutical Companies
2.4.2 Medical Device Companies
2.4.3 Other
2.5 CXO Services Market Size by Application
2.5.1 CXO Services Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global CXO Services Market Size Market Share by Application (2020-2025)
3 CXO Services Market Size by Player
3.1 CXO Services Market Size Market Share by Player
3.1.1 Global CXO Services Revenue by Player (2020-2025)
3.1.2 Global CXO Services Revenue Market Share by Player (2020-2025)
3.2 Global CXO Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CXO Services by Region
4.1 CXO Services Market Size by Region (2020-2025)
4.2 Global CXO Services Annual Revenue by Country/Region (2020-2025)
4.3 Americas CXO Services Market Size Growth (2020-2025)
4.4 APAC CXO Services Market Size Growth (2020-2025)
4.5 Europe CXO Services Market Size Growth (2020-2025)
4.6 Middle East & Africa CXO Services Market Size Growth (2020-2025)
5 Americas
5.1 Americas CXO Services Market Size by Country (2020-2025)
5.2 Americas CXO Services Market Size by Type (2020-2025)
5.3 Americas CXO Services Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CXO Services Market Size by Region (2020-2025)
6.2 APAC CXO Services Market Size by Type (2020-2025)
6.3 APAC CXO Services Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe CXO Services Market Size by Country (2020-2025)
7.2 Europe CXO Services Market Size by Type (2020-2025)
7.3 Europe CXO Services Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa CXO Services by Region (2020-2025)
8.2 Middle East & Africa CXO Services Market Size by Type (2020-2025)
8.3 Middle East & Africa CXO Services Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global CXO Services Market Forecast
10.1 Global CXO Services Forecast by Region (2026-2031)
10.1.1 Global CXO Services Forecast by Region (2026-2031)
10.1.2 Americas CXO Services Forecast
10.1.3 APAC CXO Services Forecast
10.1.4 Europe CXO Services Forecast
10.1.5 Middle East & Africa CXO Services Forecast
10.2 Americas CXO Services Forecast by Country (2026-2031)
10.2.1 United States Market CXO Services Forecast
10.2.2 Canada Market CXO Services Forecast
10.2.3 Mexico Market CXO Services Forecast
10.2.4 Brazil Market CXO Services Forecast
10.3 APAC CXO Services Forecast by Region (2026-2031)
10.3.1 China CXO Services Market Forecast
10.3.2 Japan Market CXO Services Forecast
10.3.3 Korea Market CXO Services Forecast
10.3.4 Southeast Asia Market CXO Services Forecast
10.3.5 India Market CXO Services Forecast
10.3.6 Australia Market CXO Services Forecast
10.4 Europe CXO Services Forecast by Country (2026-2031)
10.4.1 Germany Market CXO Services Forecast
10.4.2 France Market CXO Services Forecast
10.4.3 UK Market CXO Services Forecast
10.4.4 Italy Market CXO Services Forecast
10.4.5 Russia Market CXO Services Forecast
10.5 Middle East & Africa CXO Services Forecast by Region (2026-2031)
10.5.1 Egypt Market CXO Services Forecast
10.5.2 South Africa Market CXO Services Forecast
10.5.3 Israel Market CXO Services Forecast
10.5.4 Turkey Market CXO Services Forecast
10.6 Global CXO Services Forecast by Type (2026-2031)
10.7 Global CXO Services Forecast by Application (2026-2031)
10.7.1 GCC Countries Market CXO Services Forecast
11 Key Players Analysis
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza CXO Services Product Offered
11.1.3 Lonza CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Catalent
11.2.1 Catalent Company Information
11.2.2 Catalent CXO Services Product Offered
11.2.3 Catalent CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Catalent Main Business Overview
11.2.5 Catalent Latest Developments
11.3 Samsung Biologics
11.3.1 Samsung Biologics Company Information
11.3.2 Samsung Biologics CXO Services Product Offered
11.3.3 Samsung Biologics CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Samsung Biologics Main Business Overview
11.3.5 Samsung Biologics Latest Developments
11.4 FUJIFILM Diosynth Biotechnologies
11.4.1 FUJIFILM Diosynth Biotechnologies Company Information
11.4.2 FUJIFILM Diosynth Biotechnologies CXO Services Product Offered
11.4.3 FUJIFILM Diosynth Biotechnologies CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.4.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Information
11.5.2 Boehringer Ingelheim CXO Services Product Offered
11.5.3 Boehringer Ingelheim CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Boehringer Ingelheim Main Business Overview
11.5.5 Boehringer Ingelheim Latest Developments
11.6 Wuxi AppTec
11.6.1 Wuxi AppTec Company Information
11.6.2 Wuxi AppTec CXO Services Product Offered
11.6.3 Wuxi AppTec CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Wuxi AppTec Main Business Overview
11.6.5 Wuxi AppTec Latest Developments
11.7 Charles River
11.7.1 Charles River Company Information
11.7.2 Charles River CXO Services Product Offered
11.7.3 Charles River CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Charles River Main Business Overview
11.7.5 Charles River Latest Developments
11.8 Labcorp
11.8.1 Labcorp Company Information
11.8.2 Labcorp CXO Services Product Offered
11.8.3 Labcorp CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Labcorp Main Business Overview
11.8.5 Labcorp Latest Developments
11.9 Eurofins Scientific
11.9.1 Eurofins Scientific Company Information
11.9.2 Eurofins Scientific CXO Services Product Offered
11.9.3 Eurofins Scientific CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Eurofins Scientific Main Business Overview
11.9.5 Eurofins Scientific Latest Developments
11.10 PPD, Inc.
11.10.1 PPD, Inc. Company Information
11.10.2 PPD, Inc. CXO Services Product Offered
11.10.3 PPD, Inc. CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 PPD, Inc. Main Business Overview
11.10.5 PPD, Inc. Latest Developments
11.11 ICON Plc.
11.11.1 ICON Plc. Company Information
11.11.2 ICON Plc. CXO Services Product Offered
11.11.3 ICON Plc. CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 ICON Plc. Main Business Overview
11.11.5 ICON Plc. Latest Developments
11.12 Pharmaron
11.12.1 Pharmaron Company Information
11.12.2 Pharmaron CXO Services Product Offered
11.12.3 Pharmaron CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Pharmaron Main Business Overview
11.12.5 Pharmaron Latest Developments
11.13 Recipharm
11.13.1 Recipharm Company Information
11.13.2 Recipharm CXO Services Product Offered
11.13.3 Recipharm CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Recipharm Main Business Overview
11.13.5 Recipharm Latest Developments
11.14 Thermo Fisher Scientific
11.14.1 Thermo Fisher Scientific Company Information
11.14.2 Thermo Fisher Scientific CXO Services Product Offered
11.14.3 Thermo Fisher Scientific CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Thermo Fisher Scientific Main Business Overview
11.14.5 Thermo Fisher Scientific Latest Developments
11.15 AGC Biologics
11.15.1 AGC Biologics Company Information
11.15.2 AGC Biologics CXO Services Product Offered
11.15.3 AGC Biologics CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 AGC Biologics Main Business Overview
11.15.5 AGC Biologics Latest Developments
11.16 Rentschler Biopharma
11.16.1 Rentschler Biopharma Company Information
11.16.2 Rentschler Biopharma CXO Services Product Offered
11.16.3 Rentschler Biopharma CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Rentschler Biopharma Main Business Overview
11.16.5 Rentschler Biopharma Latest Developments
11.17 KBI Biopharma
11.17.1 KBI Biopharma Company Information
11.17.2 KBI Biopharma CXO Services Product Offered
11.17.3 KBI Biopharma CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 KBI Biopharma Main Business Overview
11.17.5 KBI Biopharma Latest Developments
11.18 Siegfried
11.18.1 Siegfried Company Information
11.18.2 Siegfried CXO Services Product Offered
11.18.3 Siegfried CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Siegfried Main Business Overview
11.18.5 Siegfried Latest Developments
11.19 Aenova Group
11.19.1 Aenova Group Company Information
11.19.2 Aenova Group CXO Services Product Offered
11.19.3 Aenova Group CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Aenova Group Main Business Overview
11.19.5 Aenova Group Latest Developments
11.20 GenScript
11.20.1 GenScript Company Information
11.20.2 GenScript CXO Services Product Offered
11.20.3 GenScript CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 GenScript Main Business Overview
11.20.5 GenScript Latest Developments
11.21 ProBioGen
11.21.1 ProBioGen Company Information
11.21.2 ProBioGen CXO Services Product Offered
11.21.3 ProBioGen CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 ProBioGen Main Business Overview
11.21.5 ProBioGen Latest Developments
11.22 Northway Biotech
11.22.1 Northway Biotech Company Information
11.22.2 Northway Biotech CXO Services Product Offered
11.22.3 Northway Biotech CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 Northway Biotech Main Business Overview
11.22.5 Northway Biotech Latest Developments
11.23 3P Biopharmaceuticals
11.23.1 3P Biopharmaceuticals Company Information
11.23.2 3P Biopharmaceuticals CXO Services Product Offered
11.23.3 3P Biopharmaceuticals CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.23.4 3P Biopharmaceuticals Main Business Overview
11.23.5 3P Biopharmaceuticals Latest Developments
11.24 Inotiv
11.24.1 Inotiv Company Information
11.24.2 Inotiv CXO Services Product Offered
11.24.3 Inotiv CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.24.4 Inotiv Main Business Overview
11.24.5 Inotiv Latest Developments
11.25 ChemPartner
11.25.1 ChemPartner Company Information
11.25.2 ChemPartner CXO Services Product Offered
11.25.3 ChemPartner CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.25.4 ChemPartner Main Business Overview
11.25.5 ChemPartner Latest Developments
11.26 JOINN Lab
11.26.1 JOINN Lab Company Information
11.26.2 JOINN Lab CXO Services Product Offered
11.26.3 JOINN Lab CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.26.4 JOINN Lab Main Business Overview
11.26.5 JOINN Lab Latest Developments
11.27 EVOTEC
11.27.1 EVOTEC Company Information
11.27.2 EVOTEC CXO Services Product Offered
11.27.3 EVOTEC CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.27.4 EVOTEC Main Business Overview
11.27.5 EVOTEC Latest Developments
11.28 Medicilon
11.28.1 Medicilon Company Information
11.28.2 Medicilon CXO Services Product Offered
11.28.3 Medicilon CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.28.4 Medicilon Main Business Overview
11.28.5 Medicilon Latest Developments
11.29 Crown Bioscience
11.29.1 Crown Bioscience Company Information
11.29.2 Crown Bioscience CXO Services Product Offered
11.29.3 Crown Bioscience CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.29.4 Crown Bioscience Main Business Overview
11.29.5 Crown Bioscience Latest Developments
11.30 Champion Oncology
11.30.1 Champion Oncology Company Information
11.30.2 Champion Oncology CXO Services Product Offered
11.30.3 Champion Oncology CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.30.4 Champion Oncology Main Business Overview
11.30.5 Champion Oncology Latest Developments
11.31 IQVIA
11.31.1 IQVIA Company Information
11.31.2 IQVIA CXO Services Product Offered
11.31.3 IQVIA CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.31.4 IQVIA Main Business Overview
11.31.5 IQVIA Latest Developments
11.32 Parexel
11.32.1 Parexel Company Information
11.32.2 Parexel CXO Services Product Offered
11.32.3 Parexel CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.32.4 Parexel Main Business Overview
11.32.5 Parexel Latest Developments
11.33 Syneos Health
11.33.1 Syneos Health Company Information
11.33.2 Syneos Health CXO Services Product Offered
11.33.3 Syneos Health CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.33.4 Syneos Health Main Business Overview
11.33.5 Syneos Health Latest Developments
11.34 PRA Health Sciences
11.34.1 PRA Health Sciences Company Information
11.34.2 PRA Health Sciences CXO Services Product Offered
11.34.3 PRA Health Sciences CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.34.4 PRA Health Sciences Main Business Overview
11.34.5 PRA Health Sciences Latest Developments
11.35 Medpace Holdings
11.35.1 Medpace Holdings Company Information
11.35.2 Medpace Holdings CXO Services Product Offered
11.35.3 Medpace Holdings CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.35.4 Medpace Holdings Main Business Overview
11.35.5 Medpace Holdings Latest Developments
11.36 Tigermed
11.36.1 Tigermed Company Information
11.36.2 Tigermed CXO Services Product Offered
11.36.3 Tigermed CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.36.4 Tigermed Main Business Overview
11.36.5 Tigermed Latest Developments
11.37 Boji Medical Technology
11.37.1 Boji Medical Technology Company Information
11.37.2 Boji Medical Technology CXO Services Product Offered
11.37.3 Boji Medical Technology CXO Services Revenue, Gross Margin and Market Share (2020-2025)
11.37.4 Boji Medical Technology Main Business Overview
11.37.5 Boji Medical Technology Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
